<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01574586</url>
  </required_header>
  <id_info>
    <org_study_id>BEGIN12</org_study_id>
    <nct_id>NCT01574586</nct_id>
  </id_info>
  <brief_title>Bifurcation Stenting Using 2 Link Stent Nobori Versus 3 Link Stent Xience</brief_title>
  <acronym>BEGIN</acronym>
  <official_title>A Multicenter, Randomized Trial to Compare 2 Link Nobori and 3 Link Xience Stents in Bifurcation Stenting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kurashiki Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kurashiki Central Hospital</source>
  <brief_summary>
    <textblock>
      The primary objective of this study is to make a comparison of safety and efficacy of DESs&#xD;
      with different link number (2-link Nobori and 3-link Xience) in patients with de novo true&#xD;
      bifurcation lesions.&#xD;
&#xD;
      The minimum lumen diameter of the side branch ostium in bifurcation at 8 months and the MACE&#xD;
      rate until one year after PCI will be assessed in both groups.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Minimum lumen diameter of the side branch ostium in bifurcation</measure>
    <time_frame>8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of MACE</measure>
    <time_frame>in-hospital, 30 days, 8 months, 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Coronary Stenosis</condition>
  <arm_group>
    <arm_group_label>2-link stent Nobori</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bifurcation stenting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3-link stent Xience</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bifurcation stenting</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bifurcation stenting</intervention_name>
    <description>Bifurcation stenting using 2-link stent Nobori versus 3-link stent Xience</description>
    <arm_group_label>2-link stent Nobori</arm_group_label>
    <arm_group_label>3-link stent Xience</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient eligible for percutaneous coronary intervention&#xD;
&#xD;
          2. Patient or substitute decision-maker willing to provide written informed consent,&#xD;
             which is approved by the Institutional Review Board or its equivalence&#xD;
&#xD;
          3. De novo stenosis at coronary bifurcation with up to two vessels (visually estimated&#xD;
             diameter stenosis ≥50%)&#xD;
&#xD;
          4. Second vessel at coronary bifurcation treatable with trial device during the procedure&#xD;
&#xD;
          5. True coronary bifurcation, ≥50% diameter stenosis in both the main and side branches,&#xD;
             belonging to the Medina classes 1.1.1, 1.0.1, and 0.1.1,&#xD;
&#xD;
          6. Visually estimated target lesion reference vessel diameter, 2.5-5.0 mm in the main&#xD;
             branch, ≥2.25 mm in the side branch&#xD;
&#xD;
          7. Target lesion treatable with one or two stents in both the main and side branches&#xD;
&#xD;
          8. Consensus of PCI after discussion between cardiologists and cardiac surgeons for the&#xD;
             lesion in the left main coronary artery&#xD;
&#xD;
          9. Thrombolysis in Myocardial Infarction grade ≥1 flow in both the main and side branches&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        A. General restrictions&#xD;
&#xD;
          1. Unable to be followed by the implementing medial institution&#xD;
&#xD;
          2. Life expectancy &lt;1 year&#xD;
&#xD;
          3. Acute myocardial infarction (&lt;1 week)&#xD;
&#xD;
          4. Left ventricular ejection fraction &lt;30%&#xD;
&#xD;
          5. Scheduled for elective treatment requiring antiplatelet drug Withdrawal&#xD;
&#xD;
          6. Deemed as unsuitable by the investigator or subinvestigator&#xD;
&#xD;
          7. Serum creatinine level ≥2.0 Mg/dl&#xD;
&#xD;
        B. Vascular morphological restrictions&#xD;
&#xD;
          1. Lesion proximal to coronary artery bypass graft anastomotic site (visual estimation&#xD;
             ≤5.0 mm) or including a part of coronary artery bypass grafting&#xD;
&#xD;
          2. In-stent restenosis&#xD;
&#xD;
          3. Severe calcification&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kurashiki Central Hospital</name>
      <address>
        <city>Kurashiki</city>
        <zip>710-8602</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <study_first_submitted>April 6, 2012</study_first_submitted>
  <study_first_submitted_qc>April 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2012</study_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>True Bifurcation stenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

